48
Views
0
CrossRef citations to date
0
Altmetric
Original Papers

Patient management after primary rectal cancer diagnosis. Special focus on surgical treatment for non-metastatic disease

, , , , , , , , , , , , , , , , , , & show all
Pages 208-216 | Received 30 Nov 2022, Accepted 27 Oct 2023, Published online: 14 Nov 2023

References

  • Belgian Cancer Registry. Quality indicator in oncology: rectum adenocarcinoma (2009-2017). Individual Feedback Manual. 2021.
  • Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19–23. doi: 10.1007/s003840050072.
  • Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi: 10.1097/SLA.0b013e3181b13ca2.
  • Verdin V, Weerts J, Francart D, et al. Rectal cancer treatment in a teaching hospital. Acta Chir Belg. 2017;117(1):8–14. doi: 10.1080/00015458.2016.1184906.
  • Wallace B, Schuepbach F, Gaukel S, et al. Evidence according to cochrane systematic reviews on alterable risk factors for anastomotic leakage in colorectal surgery. Gastroenterol Res Pract. 2020;2020:9057963.
  • Whittaker TM, Abdelrazek MEG, Fitzpatrick AJ, et al. Delay to elective colorectal cancer surgery and implications for survival: a systematic review and meta-analysis. Colorectal Dis. 2021;23(7):1699–1711. doi: 10.1111/codi.15625.
  • Wilkinson N. Management of rectal cancer. Surg Clin North Am. 2020;100(3):615–628. doi: 10.1016/j.suc.2020.02.014.
  • Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for Colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93(8):583–596. doi: 10.1093/jnci/93.8.583.
  • Boland MR, Reynolds I, McCawley N, et al. Liberal perioperative fluid administration is an independent risk factor for morbidity and is associated with longer hospital stay after rectal cancer surgery. Ann R Coll Surg Engl. 2017;99(2):113–116. doi: 10.1308/rcsann.2016.0280.
  • Siragusa L, Sensi B, Vinci D, et al. Volume-outcome relationship in rectal cancer surgery. Discov Oncol. 2021;12(1):11. doi: 10.1007/s12672-021-00406-9.
  • Vogel I, Reeves N, Tanis PJ, et al. Impact of a defunctioning ileostomy and time to stoma closure on bowel function after low anterior resection for rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2021;25(7):751–760. doi: 10.1007/s10151-021-02436-5.
  • Jørgensen JB, Erichsen R, Pedersen BG, et al. Stoma reversal after intended restorative rectal cancer resection in Denmark: nationwide population-based study. BJS Open. 2020;4(6):1162–1171. doi: 10.1002/bjs5.50340.
  • Koëter T, de Nes LCF, Wasowicz DK, et al. Hospital variation in sphincter-preservation rates in rectal cancer treatment: results of a population-based study in The Netherlands. BJS Open. 2021;5(4):zrab065. doi: 10.1093/bjsopen/zrab065.
  • Babakhanlou R, Larkin K, Hita AG, et al. Stoma-related complications and emergencies. Int J Emerg Med. 2022;15(1):17. doi: 10.1186/s12245-022-00421-9.
  • Moosvi SR, Manley K, Hernon J. The effect of rectal washout on local recurrence following rectal cancer surgery. Ann R Coll Surg Engl. 2018;100(2):146–151. doi: 10.1308/rcsann.2017.0202.
  • Matthiessen P, Hallböök O, Rutegård J, et al. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007;246(2):207–214. doi: 10.1097/SLA.0b013e3180603024.
  • Chioreso C, Del Vecchio N, Schweizer ML, et al. Association between hospital and surgeon volume and rectal cancer surgery outcomes in patients with rectal cancer treated since 2000: systematic literature review and meta-analysis. Dis Colon Rectum. 2018;61(11):1320–1332. doi: 10.1097/DCR.0000000000001198.
  • Gottlieb-Vedi E, Mattsson F, Lagergren P, et al. Annual hospital volume of surgery for gastrointestinal cancer in relation to prognosis. Eur J Surg Oncol. 2019;45(10):1839–1846. doi: 10.1016/j.ejso.2019.03.016.
  • Hallet J, Jerath A, Turgeon AF, et al. Association between anesthesiologist volume and short-term outcomes in complex gastrointestinal cancer surgery. JAMA Surg. 2021;156(5):479–487. doi: 10.1001/jamasurg.2021.0135.
  • Okawa S, Tabuchi T, Morishima T, et al. Hospital volume and postoperative 5-year survival for five different cancer sites: a population-based study in Japan. Cancer Sci. 2020;111(3):985–993. doi: 10.1111/cas.14309.
  • Welten VM, Wanis KN, Madenci AL, et al. The effect of facility volume on survival following proctectomy for rectal cancer. J Gastrointest Surg. 2022;26(1):150–160. doi: 10.1007/s11605-021-05092-0.
  • Giesen LJX, Olthof PB, Elferink MAG, et al. Surgery for rectal cancer: differences in resection rates among hospitals in The Netherlands. Eur J Surg Oncol. 2021;47(9):2384–2389. doi: 10.1016/j.ejso.2021.04.030.
  • Mualla NM, Hussain MR, Akrmah M, et al. The impact of postoperative complications on long-term oncological outcomes following curative resection of colorectal cancer (stage I-III): a systematic review and meta-analysis. Cureus. 2021;13(1):e12837. doi: 10.7759/cureus.12837.
  • Xanthis A, Greenberg D, Jha B, et al. Local recurrence after 'standard’ abdominoperineal resection: do we really need ELAPE? Ann R Coll Surg Engl. 2018;100(2):111–115. doi: 10.1308/rcsann.2017.0161.
  • Glimelius B. Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives. Curr Opin Oncol. 2020;32(4):377–383. doi: 10.1097/CCO.0000000000000641.
  • Bregni G, Akin Telli T, Camera S, et al. Adjuvant chemotherapy for rectal cancer: current evidence and recommendations for clinical practice. Cancer Treat Rev. 2020;83:101948. doi: 10.1016/j.ctrv.2019.101948.
  • Karimi F, Tabriz HM, Amoli HA, et al. Evaluation of the histopathologic status of rectal adenocarcinoma and its regional lymph nodes after neoadjuvant therapy, and its relation to the duration of disease-free survival. Indian J Pathol Microbiol. 2022;65(1):49–54.
  • Erlandsson J, Lörinc E, Ahlberg M, et al. Tumour regression after radiotherapy for rectal cancer - results from the randomised Stockholm III trial. Radiother Oncol. 2019;135:178–186. doi: 10.1016/j.radonc.2019.03.016.
  • López-Campos F, Martín-Martín M, Fornell-Pérez R, et al. Watch and wait approach in rectal cancer: current controversies and future directions. World J Gastroenterol. 2020;26(29):4218–4239. doi: 10.3748/wjg.v26.i29.4218.
  • Debove C, Maggiori L, Chau A, et al. What happens after R1 resection in patients undergoing laparoscopic total mesorectal excision for rectal cancer? A study in 333 consecutive patients. Colorectal Dis. 2015;17(3):197–204. doi: 10.1111/codi.12849.
  • Yang Y, Wang G, He J, et al. Gender differences in colorectal cancer survival: a meta-analysis. Int J Cancer. 2017;141(10):1942–1949. doi: 10.1002/ijc.30827.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.